← Leaderboards
Bruce D Johnson
Mayo Clinic Coll Of Medicine, Rochester
$7,142,234
Attributed
$7,221,734
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,221,734 · 11
By mechanism
R01$3,733,768 · 1
P50$2,798,511 · 2
R21$583,784 · 2
M01$105,671 · 6
Top collaborators
- Jenna-Lee Taylor1 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Timothy Mark Olson$4,741,533
- John R. Halliwill$5,302,163
- Gary C. Sieck$25,154,239
- Andre Terzic$12,998,853
- Kenneth C Beck$21,845
Others in their field
Top investigators on “Exercise”
- Marco Pahor · Wake Forest University Health Sciences$102,861,874
- Dan M Cooper · University Of California San Diego$73,946,122
- John J. Leconche · Laborers-Agc Education And Training Fund$72,386,283
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Susan M Landau · University Of California Berkeley$47,252,026
- Richard A McIndoe · Augusta University$42,262,361
Research focus
ExerciseProgramsLungFundingResearch Project GrantsCostLinkAreaGrantHeart FailureClinical ResearchHuman SubjectMalignant Neoplasm Of LungBiological SciencesMonitorApplied ResearchEvaluationResearch And DevelopmentPrincipal InvestigatorFosteringMemberResearch PersonnelStructureSuccess
Grant awards (35)
Influence of exercise training and intensity on cerebral blood flow regulation and cognitive function in mid-life adults with cardiovascular disease.$159,000
R21 · FY2023 · AG · contact PI
Pulmonary Limitations in Chronic Heart Failure$353,840
R01 · FY2014 · HL · contact PI
Pulmonary Limitations in Chronic Heart Failure$343,541
R01 · FY2013 · HL · contact PI
CB: Administration, Evaluation, and Planning$619,944
P50 · FY2012 · CA · contact PI
Developmental Research Program$145,734
P50 · FY2012 · CA · contact PI
CB: Administration, Evaluation, and Planning$599,283
P50 · FY2011 · CA · contact PI
Pulmonary Limitations in Chronic Heart Failure$364,508
R01 · FY2011 · HL · contact PI
Functional Optimization of Cardiac Resynchronization Therapy in Heart Failure$192,398
R21 · FY2011 · HL · contact PI
Developmental Research Program$129,731
P50 · FY2011 · CA · contact PI
CB: Administration, Evaluation, and Planning$629,237
P50 · FY2010 · CA · contact PI
Pulmonary Limitations in Chronic Heart Failure$364,508
R01 · FY2010 · HL · contact PI
Functional Optimization of Cardiac Resynchronization Therapy in Heart Failure$232,386
R21 · FY2010 · HL · contact PI
Developmental Research Program$139,950
P50 · FY2010 · CA · contact PI
Pulmonary Limitations in Chronic Heart Failure$364,508
R01 · FY2009 · HL · contact PI
CB: Administration, Evaluation, and Planning$239,243
P50 · FY2009 · CA · contact PI
Developmental Research Program$54,788
P50 · FY2009 · CA · contact PI
Pulmonary Limitations in Chronic Heart Failure$15,896
R01 · FY2009 · HL · contact PI
CB: Administration, Evaluation, and Planning$194,613
P50 · FY2008 · CA · contact PI
Developmental Research Program$45,988
P50 · FY2008 · CA · contact PI
Pulmonary Limitations in Chronic Heart Failure$352,761
R01 · FY2006 · HL · contact PI
Pulmonary Limitations in Chronic Heart Failure$356,634
R01 · FY2005 · HL
INFLUENCE OF BETA 2 ADRENERGIC RECEPTOR GENOTYPE ON LUNG FLUID BALANCE$30,329
M01 · FY2005 · RR
B2, ADRENERGIC RECEPTOR POLYMORPHISMS ON CARDIOPULMONARY RESPONSES TO EXERCISE$18,482
M01 · FY2005 · RR
LABORATORY TECHNIQUES TO MEASURE RECEPTOR DENSITY AND AFFINITY IN LYMPHOCYTES$2,369
M01 · FY2005 · RR
INFLUENCE OF TRANSIENT LUNG VOLUME CHANGES ON HEART RATE DURING EXERCISE$1,422
M01 · FY2005 · RR
Pulmonary Limitations in Chronic Heart Failure$393,676
R01 · FY2004 · HL
B2AR Polymorphism &Cardiopulmonary Response to Exercise$45,654
M01 · FY2004 · RR
Lung Volume Changes on Heart Rate during Exercise in CHF$5,098
M01 · FY2004 · RR
Cardiac Output During Exercise in Patients with COPD$2,317
M01 · FY2004 · RR
Pulmonary Limitations in Chronic Heart Failure$429,941
R01 · FY2003 · HL
Pulmonary Limitations in Chronic Heart Failure$36,125
R01 · FY2003 · HL
Pulmonary Limitations in Chronic Heart Failure$357,830
R01 · FY2002 · HL
INFLUENCE OF CHEST WALL RESTRICTION ON CARDIAC FUNCTION DURING EXERCISE$0
M01 · FY2002 · RR
INFLUENCE OF CHEST WALL RESTRICTION ON CARDIAC FUNCTION DURING EXERCISE$0
M01 · FY2001 · RR
INFLUENCE OF CHEST WALL RESTRICTION ON CARDIAC FUNCTION DURING EXERCISE$0
M01 · FY2000 · RR